Inari Medical Inc
NARI
Market Cap$2.23B
Close$
$-37.62
200.7% downside
Current Fair Value
200.7% downsideOvervalued by 200.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.23 Billion |
|---|---|
| Enterprise Value | $2.11 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.03 |
| Beta | 0.0 |
| Outstanding Shares | 57,960,555 |
| Avg 30 Day Volume | 1,037,298 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1361.15 |
|---|---|
| PEG | 6965.54 |
| Price to Sales | 4.67 |
| Price to Book Ratio | 4.67 |
| Enterprise Value to Revenue | 4.28 |
| Enterprise Value to EBIT | -150.47 |
| Enterprise Value to Net Income | -1291 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Inari Medical Inc
456 employeesInari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based...